The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...

The dose of paclitaxel used in the new approach was 16-fold lower than that typically used in free paclitaxel, but with similar efficacy.

Patients with HER2 gene amplification, normal left ventricular ejection fraction (LVEF), and resistant relapse after first- or second-line paclitaxel/carboplatin chemotherapy received paclitaxel ...

Pharmacogenomics. 2008;9(6):671-674. Paclitaxel (Taxol ®) has a broad activity spectrum and is clinically used, often in combination with carboplatin, to treat breast, ovarian and lung cancer.

Theoretically, you could put any number of chemotherapy drugs in these packets, not just paclitaxel." And years of experience with chemotherapy show that delivery matters. "The same drug can have ...

Thymic carcinoma, a rare cancer, is often associated with poor prognosis in advanced or recurrent stages. However, its rarity has delayed the development of novel pharmacotherapy. Now, researchers ...

The addition of paclitaxel to anthracycline-based adjuvant chemotherapy significantly improves relapse-free survival (RFS) in patients with operable breast cancer, according to a new study.

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...